Safety fears hang over pioneering Novartis MS pill
Posted: Sat Jun 05, 2010 3:23 am
* Gilenia leads U.S. race as first multiple sclerosis pill
* FDA panel to vote on drug June 10, staff documents June 8
* Cancer and heart safety concerns expected to loom large
* Rival drugs in works from Merck KGaA, Teva, Sanofi, Biogen
Swiss drugmaker Novartis AG's race to get the first multiple sclerosis pill to market reaches a pivotal point next week when U.S. experts vote on whether Gilenia should be recommended for approval.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1309